Docs rate exhibits as better than ads

Share this article:
Physicians prefer exhibits at medical meetings to some other modes of learning about new drugs and technologies, a study suggests.

M|C Communications polled attendees at a Pri-Med meeting earlier this year—212 before and 182 after. The Healthcare Convention & Exhibitors Association presented the data in June.

Sixty-six percent favor getting information on new drugs from exhibitors, vs. 16% who prefer journal ads and 69% who prefer journal articles. For medical technology information, most clearly prefer exhibitors.

In addition, almost half said their offices restrict access by detailers or plan to within the next six months.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.

Five things for Pharma Marketers to Know: Thursday, August 28

Five things for Pharma Marketers to Know: Thursday, ...

Human testing of GSK's Ebola virus starts next week, menopause is a costly healthcare concern, and a small conversation with pharmacists may have a big impact.